Who
Stephen P. Carey
SVP & CFO
Company insider
Files Form 4 as: SVP & CFO, ANI Pharmaceuticals.
In numbers
- Trades disclosed
- 91
- Buys
- 0
- Sells
- 12
- Bought
- $0
- Sold
- $10.6M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 6 May 2016
- Last trade
- 29 Sep 2026
- Last filed
- 30 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 29 Sep 2026filed 30 Sep 2026 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $208K2,850 at $73.00 | filing |
| 29 Sep 2026filed 30 Sep 2026 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $208K2,850 at $73.00 | filing |
| 31 Aug 2026filed 1 Sep 2026 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $207K2,850 at $72.80 | filing |
| 31 Aug 2026filed 1 Sep 2026 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $207K2,850 at $72.80 | filing |
| 29 Jul 2026filed 30 Jul 2026 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $232K2,850 at $81.36 | filing |
| 29 Jul 2026filed 30 Jul 2026 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $232K2,850 at $81.36 | filing |
| 2 Jul 2026filed 6 Jul 2026 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | $164K3,313 at $49.51 | filing |
| 2 Jul 2026filed 6 Jul 2026 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $285K3,313 at $86.00 | filing |
| 2 Jul 2026filed 6 Jul 2026 | ANIP ANI Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | $164K3,313 at $49.51 | filing |
| 2 Jul 2026filed 6 Jul 2026 | ANIP ANI Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | $164K3,313 at $49.51 | filing |
| 2 Jul 2026filed 6 Jul 2026 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | $164K3,313 at $49.51 | filing |
| 2 Jul 2026filed 6 Jul 2026 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $285K3,313 at $86.00 | filing |
| 29 Jun 2026filed 30 Jun 2026 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $240K2,850 at $84.12 | filing |
| 29 Jun 2026filed 30 Jun 2026 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $240K2,850 at $84.12 | filing |
| 5 Jun 2026filed 9 Jun 2026 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | $164K3,312 at $49.51 | filing |
| 5 Jun 2026filed 9 Jun 2026 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $265K3,312 at $80.00 | filing |
| 5 Jun 2026filed 9 Jun 2026 | ANIP ANI Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | $164K3,312 at $49.51 | filing |
| 5 Jun 2026filed 9 Jun 2026 | ANIP ANI Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | $164K3,312 at $49.51 | filing |
| 5 Jun 2026filed 9 Jun 2026 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | $164K3,312 at $49.51 | filing |
| 5 Jun 2026filed 9 Jun 2026 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $265K3,312 at $80.00 | filing |
News
ANI Pharmaceuticals to Discuss Third Quarter 2026 Financial Results on November 5, 2026 at 8:00 a.m. ETANIP · manilatimes.net · 23 Oct 2026
0 headlines in the last 90 days name Stephen P. Carey; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.